By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ObsEva 

Chemin des Aulx, 12
1228 Plan-les-Ouates
  Geneva    Switzerland
Phone: n/a Fax: n/a


SEARCH JOBS








Company News
ObsEva (OBSV) Reports Second Quarter 2017 Financial Results And Provides Business Update 8/16/2017 10:26:04 AM
ObsEva (OBSV) To Hold Second Quarter 2017 Financial Results/Business Update Call On August 15, 2017 And Present At Wedbush Pacgrow Healthcare Conference In NYC On August 16, 2017 8/7/2017 12:05:55 PM
ObsEva (OBSV) Announces Presentations Related To Its Assisted Reproductive Technology (ART) And Pre-Term Labor (PTL) Development Programs At ESHRE 2017 Annual Meeting 6/29/2017 8:24:16 AM
ObsEva (OBSV) Announces The Completion Of A Phase I PK/PD Clinical Trial Evaluating Different Doses Of OBE2109 And Add-Back Therapy 6/7/2017 8:26:25 AM
ObsEva (OBSV) Announces The Completion Of A Phase I Drug-Drug Interaction Study With OBE022 5/18/2017 10:44:37 AM
ObsEva (OBSV) Reports First Quarter 2017 Financial Results and Business Update 5/18/2017 10:42:10 AM
ObsEva (OBSV) To Hold First Quarter 2017 Financial Results And Business Update Call On Thursday, May 18, 2017 5/11/2017 11:14:42 AM
ObsEva (OBSV) Initiates Phase III Clinical Program For OBE2109 In Uterine Fibroids 4/25/2017 9:57:20 AM
ObsEva (OBSV) To Present Pharmacology Results Demonstrating OBE022 Exerts A Synergistic Effect In Combination With Standard Of Care In Animal Model For Preterm Labor 3/17/2017 10:56:27 AM
ObsEva (OBSV) Starts Phase III Clinical Program For Nolasiban In ART 3/7/2017 8:59:06 AM
123
//-->